TMCI - Treace Medical Concepts, Inc. Book Valuation of Business

Corporate emblem and logo of treace.com (TMCI)

Treace Medical Concepts (TMCI) develops advanced implants for foot surgery, securing high profitability and sustainable FCF through its patent portfolio. This price chart on the GURU.Markets platform is currently at 0.07. Treace Medical Concepts (TMCI) is expanding the Lapiplasty system by attracting new patients and training physicians. Business growth relies on direct sales and the development of surgical competencies without employing a merger strategy.

Treace Medical Concepts Inc (TMCI) - Company Book Value from 07/04/2022 to 10/28/2026
Mass-produced product of Treace Medical

Assessing the investment potential of Treace Medical Concepts (TMCI) requires comparing market value with tangible assets. By analyzing the company's equity dynamics on the balance sheet, an investor can identify the net equity value as determined by daily trading. Growth in this metric confirms asset accumulation, while a decline indicates hidden risks. This is critical for Treace Medical Concepts (TMCI) due to its dependence on the adoption of new systems by surgeons. Insurance limitations and legal disputes could directly reduce profitability and asset value.

Competitor analysis for Treace Medical Concepts

BSX - Company Net Assets|Edwards Lifesciences - Book Capitalization|RMD (resmed.com) - Book Valuation of Business|PODD: Company Book Value|Book Valuation of Business ZBH|COO - Company Book Value|Net Asset Value Align Corp (ALGN)|GMED: Book Capitalization|Total Stockholders' Equity TransMedics Organ Care System TMDX|ATEC: Book Capitalization|AORT - Company Net Assets|DJO Global - Book Capitalization|Integra LifeSciences Inc. (IART) - Book Valuation of Business|ESTA (Establishment Labs) - Book Capitalization|Book Capitalization BBNX|Company Book Value IRADIMED (IRMD)|Company Book Value Embecta Corp (EMBC)|Book Capitalization TNDM|AXGN - Book Valuation of Business|Company Net Assets SI-BONE, Inc.|OFIX - Net Asset Value|Book Capitalization BVS|OrthoPediatrics (KIDS) - Total Stockholders' Equity|Book Capitalization Strata Critical Medical Corp (SRTA)|Accounting Capitalization Carlsmed Medical (CARL)|RxSight, Inc. (RXST) - Company Net Assets|Accounting Value of Company CLPT (clearpointneuro.com)|Stereotaxis - Company Book Value|Company Net Assets Neuronetics Inc. STIM|SGHT (Sight Sciences, Inc) - Book Capitalization|OBIO - Total Stockholders' Equity|Book Capitalization anikatherapeutics.com|inspiremd.com (NSPR) - Accounting Capitalization|ZJYL: Book Capitalization|Book Valuation of Business Vivani|Book Capitalization XTNT (Xtant Medical Holdings)|Company Net Assets NeuroOne Medical Technologies Corp. (NMTC)|Book Capitalization MODD (Modular Medical, Inc.)|myomo.com - Book Capitalization|COCH - Company Book Value|Vivos Therapeutics Inc. (VVOS) - Company Book Value|Company Net Assets enVVeno NVNO|Sintx Technologies, Inc. (SINT) - Accounting Value of Company|Book Capitalization TNON (Tenon Medical, Inc.)|Total Stockholders' Equity LFWD|AMIX: Company Book Value|Book Value of Business INVO Bioscience IVF|Company Net Assets BBLG (Bone Biologics Corporation)|Book Capitalization Axonics, Inc AXNX|Book Capitalization BIOL (BIOLASE, Inc.)|DYNT: Book Valuation of Business|Company Book Value paragon28.com (FNA)|INVO (INVO Bioscience) - Net Asset Value